Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) has cumulatively repurchased shares totaling 1.23%, amounting to 61.09 million yuan.
Guizhou Sanli (603439.SH) announced that on September 20, 2024, the company completed a transaction through voluntary trading...
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) announced that as of September 20, 2024, the company had repurchased a total of 5.0317 million shares through centralized bidding trading, accounting for 1.23% of the total share capital of the company as of the date of this announcement. The highest repurchase price was RMB 13.12 per share, and the lowest repurchase price was RMB 11.71 per share, with a total amount of funds used for repurchase of RMB 61.0931 million (excluding transaction costs).
Related Articles
REFIRE (02570) repurchased 5,000 shares at a cost of HK$715,000 on October 14th.
On October 14, Consun Pharma (01681) spent HK$4.8951 million to buy back 320,000 shares.
SIS INT'L (00529) will invest about 8.349 million Hong Kong dollars to acquire 50.01% stake in Gestetner and intends to make a mandatory tender offer to the remaining shareholders.
REFIRE (02570) repurchased 5,000 shares at a cost of HK$715,000 on October 14th.
On October 14, Consun Pharma (01681) spent HK$4.8951 million to buy back 320,000 shares.
SIS INT'L (00529) will invest about 8.349 million Hong Kong dollars to acquire 50.01% stake in Gestetner and intends to make a mandatory tender offer to the remaining shareholders.
RECOMMEND
